Season 9, Episode 9 - Rifaximin for Hepatic Encephalopathy: Balancing Benefits and Risks in the Era of Antimicrobial Resistance

For World Antimicrobial Awareness Week 2025 (“Act Now: Protect Our Present, Secure Our Future”), this EASL Studio explores the balance between rifaximin’s benefits in hepatic encephalopathy and the global challenge of antimicrobial resistance.

Faculty: Debbie Shawcross (Moderator), Rajiv Jalan (Faculty), Vish Patel (Faculty), Jonel Trebicka (Faculty)